ATE134705T1 - Rekombinantes hyopneumoniae antigen und dessen verwendung - Google Patents

Rekombinantes hyopneumoniae antigen und dessen verwendung

Info

Publication number
ATE134705T1
ATE134705T1 AT89111748T AT89111748T ATE134705T1 AT E134705 T1 ATE134705 T1 AT E134705T1 AT 89111748 T AT89111748 T AT 89111748T AT 89111748 T AT89111748 T AT 89111748T AT E134705 T1 ATE134705 T1 AT E134705T1
Authority
AT
Austria
Prior art keywords
recombinant
kda
hyopneumoniae antigen
antigen
hyopneumoniae
Prior art date
Application number
AT89111748T
Other languages
English (en)
Inventor
Daryl H Faulds
Emily Brooks
William H Andrews
Carol Lory
Original Assignee
Ml Technology Ventures
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/334,586 external-priority patent/US5240706A/en
Application filed by Ml Technology Ventures filed Critical Ml Technology Ventures
Application granted granted Critical
Publication of ATE134705T1 publication Critical patent/ATE134705T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT89111748T 1988-06-29 1989-06-28 Rekombinantes hyopneumoniae antigen und dessen verwendung ATE134705T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21324888A 1988-06-29 1988-06-29
US07/334,586 US5240706A (en) 1989-04-07 1989-04-07 Intranasal administration of Mycoplasma hyopneumoniae antigen
US34196889A 1989-04-21 1989-04-21

Publications (1)

Publication Number Publication Date
ATE134705T1 true ATE134705T1 (de) 1996-03-15

Family

ID=27395838

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89111748T ATE134705T1 (de) 1988-06-29 1989-06-28 Rekombinantes hyopneumoniae antigen und dessen verwendung

Country Status (5)

Country Link
EP (1) EP0359919B1 (de)
JP (1) JPH02291271A (de)
AT (1) ATE134705T1 (de)
DE (1) DE68925769T2 (de)
GR (1) GR3019356T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0475185A1 (de) * 1990-08-27 1992-03-18 Nippon Flour Mills Co., Ltd. DNA's, die für ein Oberflächenantigen von Mychoplasma hyopneumoniae kodidieren, DNA Fragmente für Primer, rekombinante antigene Peptide und diagnostische Methode für Mycoplasma Pneumoniae vom Schwein unter Nutzung derselben
USRE39494E1 (en) 1992-02-27 2007-02-27 Intervet Inc. Inactivated mycoplasma hyopneumoniae and uses therefor
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
WO1995009870A1 (en) * 1993-10-07 1995-04-13 Iowa State University Research Foundation, Inc. Characterization of mycoplasma hyopneumoniae adhesins
AU4825699A (en) * 1998-06-19 2000-01-05 Genzyme Corporation Identification and use of differentially expressed genes and polynucleotide sequences
AUPP727398A0 (en) * 1998-11-20 1998-12-17 Commonwealth Scientific And Industrial Research Organisation Methods of identifying antigen gene sequences
WO2014121433A1 (zh) * 2013-02-05 2014-08-14 财团法人农业科技研究院 抗霉浆菌的亚单位疫苗
RU2668799C1 (ru) * 2017-09-08 2018-10-02 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp.
RU2695679C1 (ru) * 2018-09-11 2019-07-25 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp.
RU2759427C2 (ru) * 2019-07-08 2021-11-12 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp
CN111925452B (zh) * 2020-10-19 2020-12-18 苏州世诺生物技术有限公司 猪肺炎支原体基因工程亚单位疫苗、其制备方法及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2565825B1 (fr) * 1984-06-15 1990-07-13 Centre Nat Rech Scient Vaccin contre les maladies dues a des microorganismes tels que des mycoplasmes, sa preparation et membranes de microorganismes en tant que principe actif
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
HU208550B (en) * 1986-07-25 1993-11-29 Synergen Inc Process for producing polypeptides with recombinant dns technic for diagnostizing micoplasmic infections of pigs
EP0283840A3 (de) * 1987-03-26 1989-08-09 Ml Technology Ventures, L.P. Mycoplasma hyopneuminiae-Antigen und seine Vewendungen

Also Published As

Publication number Publication date
JPH02291271A (ja) 1990-12-03
DE68925769D1 (de) 1996-04-04
DE68925769T2 (de) 1996-08-08
EP0359919B1 (de) 1996-02-28
EP0359919A3 (en) 1990-10-03
GR3019356T3 (en) 1996-06-30
EP0359919A2 (de) 1990-03-28

Similar Documents

Publication Publication Date Title
DE69529219T2 (de) Helicobacter proteine und impstoffe
DE69333110D1 (de) Mit dem cytotoxin von helicobacter pylori assoziiertes, immunodominantes antigen verwendbar in impfstoffen und zur diagnose
DE69019412T2 (de) Absorptionsmikroskopie und/oder -spektroskopie mit Abtastmikroskopiesteuerung.
DK69890D0 (da) Monoklonale antistoffer, der er reaktive med cachetin
DE3879025D1 (de) Kompressionsknochenklammer.
IT8409344A1 (it) Procedimento per la trasmissione di informazioni e/o comandi, in particolare per l'uso in ferrovia
NL300400I1 (en) Method and manufacture of an acellular vaccine comprising Bordetella pertussis antigens
ATE134705T1 (de) Rekombinantes hyopneumoniae antigen und dessen verwendung
DK228190D0 (da) Rajgraespollenallergen
DE69419966T2 (de) Impstoff gegen Streptococcus suis-Infektion
DE69116321D1 (de) Immunostimulierendes Mittel das Interleukin-2 und 5'-Deoxy-5-fluorouridin enthält
EP0299354A3 (en) Monoclonal antibodies against protein e7 of the human papilloma virus type 16, their production process and their use
ATE111292T1 (de) Heizen von lagern und dergleichen.
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
DE58907546D1 (de) Substituierte Naphthacen-5,12-dione und deren Verwendung.
IL139495A0 (en) Moraxella catarrhalis proteins
AU653861B2 (en) Respiratory disease vaccine for cats
ATE82348T1 (de) Planelement-verbund.
ATE114464T1 (de) Verwendung von zofenopril zur herstellung von medikamenten gegen rheumatoide arthritis.
DE3885715D1 (de) Fluor enthaltende Trifluormethylaminobenzole und deren Herstellung.
DE69107618T2 (de) Dispersionen und emulsionen.
DE69128095D1 (de) Azelluläre impfstoffe
SE8400782D0 (sv) Mutterkornalkaloide, ihre herstellung und verwendung
IT8820721A0 (it) Procedimento per l'inserimento di guarnizioni perimetrali in pannelli e simili e macchina per l'esecuzione del procedimento.
IT8907004V0 (it) Corpo in due meta' per interruttori, commutatori elettrici e simili.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee